---
title: LSX Blog | Sarah Dobson
description: "Sarah has a first class Bachelor of Science Degree in Chemistry from the University of York, where she gained the Whinfield prize for highest overall academic achievement for BSc candidates in her year. She continued her studies at the same University, graduating with a PhD in Chemistry with a thesis entitled “Structural studies of the malarial proteins PfEMP1 and MIF from Plasmodium falciparum”.

She has a particular interest in pharmaceuticals, polymer chemistry, coatings, plastics and biotechnology due to her background in both chemistry and biochemistry.

Sarah then spent two years working as a post-doctoral training fellow at the Institute of Cancer Research in the joint Divisions of Cancer Therapeutics and Structural Biology. Here she was an integral member of a large drug discovery team with the aim of developing novel cancer therapeutics against high profile oncoproteins using protein-ligand X-ray crystallography."
---

[![LSX The Network for Life Science Executive Leaders](https://www.lsxleaders.com/hubfs/lsx%20f.jpg "LSX The Network for Life Science Executive Leaders")](https://www.lsxleaders.com/)

![LSX Resources](https://www.lsxleaders.com/hs-fs/hubfs/Blog-2.png?width=1680&name=Blog-2.png "LSX Resources")

Written By   
<https://www.lsxleaders.com/blog/author/>

# [LSX](https://www.lsxleaders.com/blog/author/sarah-dobson)

 1 January 1970

### Posts by Sarah Dobson

- Prev
- - [Longevity Leaders (23)](https://www.lsxleaders.com/blog/author/longevity-leaders)
    - [LSX (22)](https://www.lsxleaders.com/blog/author/lsx)
- Next

### Resources

A collection of webinars, blogs and resources from LSX’s team and community – focused on connecting biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

### CATEGORIES

- [Longevity (25)](https://www.lsxleaders.com/blog/topic/longevity)
- [Ageing Well (17)](https://www.lsxleaders.com/blog/topic/ageing-well)
- [Digital Health (16)](https://www.lsxleaders.com/blog/topic/digital-health)
- [Healthtech (13)](https://www.lsxleaders.com/blog/topic/healthtech)
- [Financing Longevity (12)](https://www.lsxleaders.com/blog/topic/financing-longevity)
- [Ageing Science (11)](https://www.lsxleaders.com/blog/topic/ageing-science)
- [Medtech (5)](https://www.lsxleaders.com/blog/topic/medtech)
- [Healthcare (4)](https://www.lsxleaders.com/blog/topic/healthcare)
- [Wellness (3)](https://www.lsxleaders.com/blog/topic/wellness)
- [Preclinical (1)](https://www.lsxleaders.com/blog/topic/preclinical)

##### ABOUT

[LSX](https://www.lsxleaders.com/) is the Life Science eXecutive partnering community.

 

We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

##### EVENTS

[Female Founders](https://www.lsxleaders.com/female-founders)

[Inv€$tival Showcase](https://www.lsxleaders.com/investival-showcase)

[European Lifestars Awards](https://www.lsxleaders.com/lifestars-awards)

[LSX Nordic Congress](https://www.lsxleaders.com/lsx-nordic-congress)

[LSX USA Congress](https://www.lsxleaders.com/lsx-usa-congress)

[LSX World Congress](https://www.lsxleaders.com/lsx-world-congress)

[RNA Leaders Europe](https://www.lsxleaders.com/rna-leaders-world-congress)

[RNA Leaders USA](https://www.lsxleaders.com/rna-leaders-usa-congress)

[The $yndicate](https://www.lsxleaders.com/syndicate-investment)

[Workforce Wellbeing](https://www.lsxleaders.com/workforce-wellbeing-congress)

##### CONNECT

[Message us](https://www.lsxleaders.com/contact-us)

[Home](https://www.lsxleaders.com/)

[LSX](https://www.lsxleaders.com/)  
Informa Connect, 240 Blackfriars Road, London SE1 8BF, United Kingdom

 

[![Twitter](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-twitter.png?width=23&height=24&name=Biotech-twitter.png "Twitter")](https://twitter.com/LSXLeaders)    [![Facebook](https://www.lsxleaders.com/hs-fs/hubfs/fbook%20option%203.png?width=24&height=24&name=fbook%20option%203.png "Facebook")](https://facebook.com/LSXLeaders)    [![Youtube](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-youtube.png?width=23&height=24&name=Biotech-youtube.png "Youtube")](https://www.youtube.com/channel/UCBjBilvMaUhkgWLjQ95NIQg)    [![Linkedin](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-Linkedin.png?width=23&height=24&name=Biotech-Linkedin.png "Linkedin")](https://www.linkedin.com/company/lsx-leaders/)

 

[![Net Zero Website Logo](https://tree-nation.com/images/tracking/label-co2-website-black-en.png) ](https://tree-nation.com/profile/impact/lsx-ltd#co2)

[contact](https://www.lsxleaders.com/contact-us) | [privacy policy](https://www.lsxleaders.com/privacy-policy) | [good conduct policy](https://www.lsxleaders.com/good-conduct-policy) | [anti-slavery policy](https://www.lsxleaders.com/anti-slavery-policy) | [anti-money laundering & financial crime policy](https://www.lsxleaders.com/anti-money-laundering-financial-crime-policy) | [diversity & inclusion policy](https://www.lsxleaders.com/diversity-inclusion-policy) | [terms & conditions](https://www.lsxleaders.com/terms-conditions)  
© 2022 all rights reserved by LSX Ltd